← All organizations

Orano

For profitWebsite ↗

Also known as: Orano Med LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2025

Timeline

2000s

Sep 1, 2001
Orano— Founded

Drugs by trial phase (3 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

²¹²pb-dotam-grpr1

Indications

Studied for

Neuroendocrine Tumors

Recent trials (4)

NCT07278479CollaboratorPhase 1/Phase 2Dec 31, 2025
NCT05283330Lead sponsorPhase 1May 31, 2022
NCT05153772CollaboratorPhase 2Dec 1, 2021
NCT03466216CollaboratorPhase 1Feb 5, 2018

Details

Founded: Courbevoie, FR Sep 1, 2001
Last known activity: Dec 31, 2025